Palamur Bio Torus Vaccines Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Palamur Bio Torus Vaccines
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TG2021PTC152992
- Company No.
152992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2021
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Palamur Bio Torus Vaccines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Kankanala  | Managing Director | 09-Jul-2021 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayaragavan Thiruvengadam | Director | 09-Jul-2021 | Current |
| Ravindranath Gandlur | Director | 09-Jul-2021 | Current |
| Lakshmi Gandlur | Director | 09-Jul-2021 | Current |
Financial Performance of Palamur Bio Torus Vaccines.
Enhance accessibility to Palamur Bio Torus Vaccines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Palamur Bio Torus Vaccines?
Unlock access to Palamur Bio Torus Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Torus Vaccines Private LimitedRavindranath Gandlur and Lakshmi Gandlur are mutual person
Torus Biosciences Private LimitedRavindranath Gandlur is a mutual person
Palamur Biosciences Private LimitedVijayaragavan Thiruvengadam and Venkat Kankanala are mutual person
- Palamur Genetics Services Private Limited
Vijayaragavan Thiruvengadam and Venkat Kankanala are mutual person
Lab Links Bio-Tech Private LimitedRavindranath Gandlur is a mutual person
Veear Infexchange Private LimitedVijayaragavan Thiruvengadam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Palamur Bio Torus Vaccines?
Palamur Bio Torus Vaccines has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Palamur Bio Torus Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Palamur Bio Torus Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.